» Authors » Jukka Rajantie

Jukka Rajantie

Explore the profile of Jukka Rajantie including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 420
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mottonen M, Hiltunen L, Rajantie J, Juntti H, Makipernaa A
Duodecim . 2015 Jan; 130(20):2108-11. PMID: 25558609
We describe three previously healthy children who developed acute extensive bruises about two weeks after a mild stomach bug. Coagulation tests revealed a shortened thromboplastin time (TT), long PT time,...
2.
Helve O, Korppi M, Qvist E, Rajantie J, Heikinheimo M
Duodecim . 2013 Feb; 129(1):64-9. PMID: 23431884
Regular audit of training of specialist physicians by means of comparable methods is a recommended means to take care of immediate quality assessment of the training. An audit group consisting...
3.
Ojala T, Polinati P, Manninen T, Hiippala A, Rajantie J, Karikoski R, et al.
Pediatr Res . 2012 Jul; 72(4):432-7. PMID: 22797137
Background: We report a new mutation in the human DNAJC19 gene that causes early onset dilated cardiomyopathy syndrome (DCMA). Methods: Two brothers of Finnish origin presented with an unusual combination...
4.
Rosthoj S, Rajantie J, Treutiger I, Zeller B, Tedgard U, Henter J
Acta Paediatr . 2012 Mar; 101(7):761-6. PMID: 22429281
Aim: To describe the clinical course, morbidity and platelet recovery in an unselected Nordic cohort of children with chronic Immune Thrombocytopenic Purpura (ITP). Methods: Prospective 5-year follow-up of 96 children...
5.
Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al.
Pediatr Nephrol . 2012 Feb; 27(6):933-9. PMID: 22311342
Background: Corticosteroids have been shown not to prevent the development of Henoch-Schönlein nephritis. However, long-term follow-up data are scarce. Methods: The long-term outcome of patients in a randomized placebo-controlled prednisone...
6.
Rajantie J
Duodecim . 2011 Nov; 127(19):2081-6. PMID: 22073540
Thrombocytopenia associated with ITP in children usually returns to normal within a couple of months. Drug therapies are required to treat hemorrhages in approximately one fifth of the patients. Intravenously...
7.
Jauhola O, Ronkainen J, Autio-Harmainen H, Koskimies O, Ala-Houhala M, Arikoski P, et al.
Pediatr Nephrol . 2011 Jun; 26(12):2159-66. PMID: 21626222
Knowledge about how to treat severe Henoch-Schönlein nephritis (HSN) is scarce. The aim of our study is to compare cyclosporine A (CyA) and methylprednisolone pulses (MP) in the treatment of...
8.
Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al.
Arch Dis Child . 2010 Sep; 95(11):877-82. PMID: 20852275
Objective: To assess the risk factors for developing Henoch-Schönlein purpura nephritis (HSN) and to determine the time period when renal involvement is unlikely after the initial disease onset. Design: A...
9.
Rajantie J
Duodecim . 2010 Jul; 126(10):1137-44. PMID: 20597343
Thalassemias are a group of autosomically recessively inherited diseases involving a decreased production of structurally normal hemoglobin chains. The clinical picture of thalassemias ranges from fatal to symptomless and is...
10.
Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al.
Arch Dis Child . 2010 Apr; 95(11):871-6. PMID: 20371584
Objective: To describe the extrarenal symptoms and clinical course of Henoch-Schönlein purpura (HSP). Design: A prospective national multicentre trial with 6-month follow-up. Patients A total of 223 newly diagnosed paediatric...